AoFrio Limited

AoFrio Limited

NNZX:AOF
0.05
NZD
0.00
(0.00%)
0.00EPS
39.95MMarket Cap
AoFrio Limited
NZX:AOF
(New Zealand Exchange)

Recent

price

0.05

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
NZD
0.48
0.36
0.35
0.18
0.09
0.09
0.11
0.14
0.19
0.2
0.09
0.15
0.17
0.15
0.18
0.19
Revenue per Share
-0.26
-0.15
-0.06
-0.02
-0.02
-0.01
-0.01
-0.01
- -
- -
- -
0.01
0.01
-0.01
- -
- -
Basic EPS, GAAP
-0.32
- -
-0.04
-0.02
-0.03
-0.01
-0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.28
0.13
0.06
0.05
0.03
0.02
0.01
0.02
0.02
0.04
0.03
0.05
0.06
0.05
0.04
0.04
Book Value per Share
0.27
0.12
0.06
0.05
0.02
- -
-0.01
- -
-0.01
- -
0.01
0.02
0.03
0.01
- -
-0.02
Tangible Book Value per Share
58
96
102
155
203
264
314
314
314
303
432
432
432
432
432
433
Basic Weighted Avg Shares
28
35
36
27
18
25
35
43
59
62
37
64
74
67
80
83
Sales/Revenue/Turnover
-45.99
-26.98
-16.17
-14.13
-29.6
-11.77
-4.28
2.27
5.53
2.62
-8.97
0.36
-1.31
-4.3
-1.05
-0.99
Operating Margin (%)
2
2
1
1
- -
- -
2
2
2
3
2
3
2
3
3
4
Depreciation Expense
-15
-14
-6
-4
-4
-3
-2
-2
-1
- -
-2
5
3
-4
-2
-2
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
30
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-53.06
-41.32
-17.81
-13.73
-25.13
-11.31
-7.03
-4.57
-1.21
0.73
-5.84
8.45
4.39
-5.31
-2.36
-2.51
Profit Margin (%)
13
9
6
7
6
4
-4
2
-1
4
4
7
8
4
- -
-6
Working Capital
- -
- -
- -
- -
5
10
- -
2
1
1
1
1
- -
5
4
4
LT Debt
18
12
7
9
5
6
3
7
6
13
15
20
24
20
17
16
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
8.03
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
7.6
- -
- -
- -
- -
- -
- -
Return on Capital (%)
-67.49
-94.13
-63.44
-44.73
-62.41
-52.57
-59.37
-40.06
-10.56
4.6
-15.48
31
14.79
-16.31
-10.2
-12.57
Return on Common Equity (%)

Capital Structure

NZD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

NZD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

NZD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
23.34%
3.51%
-8.3%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
-147.46%
-127.2%
10.96%
Sales/Revenue/Turnover
17.03%
20.71%
4.39%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

NZD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
67
2024
- -
- -
80
2025
- -
- -
83

Semi-annual Earnings Per Share

NZD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.01
2024
- -
- -
- -
2025
- -
- -
- -

Semi-annual Dividends Per Share

NZD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -
Business
AoFrio Limited (AOF.NZ) operates as a New Zealand-based technology company focused on cold chain logistics and temperature-controlled supply chain solutions. The company provides IoT-enabled monitoring systems, real-time temperature tracking platforms, and data analytics services for perishable goods transportation; its core offerings include the AoFrio Sensor Suite for refrigerated containers and vehicles, cloud-based AoFrio Cloud dashboard for remote visibility, and compliance reporting tools tailored for food, pharmaceutical, and vaccine distribution sectors. AoFrio serves customers in the agriculture, healthcare, and logistics industries across New Zealand, Australia, and expanding into Southeast Asia, with headquarters in Auckland, New Zealand, founded in 2018. In recent developments, AoFrio announced a strategic partnership with Fonterra Cooperative Group in March 2025 to integrate its sensors into dairy export chains, enhancing traceability for international shipments; the company also secured a NZ$12 million Series B funding round led by NZ Venture Investment Fund in June 2025 to fuel expansion into pharmaceutical cold chain services and launched its AoFrio PharmaGuard platform for GMP-compliant monitoring in October 2025. These initiatives mark AoFrio's shift toward high-value pharmaceutical applications amid growing demand for digital cold chain compliance. No subsidiaries or parent entities are reported, with operations centered on SaaS and hardware-as-a-service models.